77 related articles for article (PubMed ID: 21114487)
21. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
[TBL] [Abstract][Full Text] [Related]
22. Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.
Strassmann G; Fong M; Freter CE; Windsor S; D'Alessandro F; Nordan RP
J Clin Invest; 1993 Nov; 92(5):2152-9. PubMed ID: 8227330
[TBL] [Abstract][Full Text] [Related]
23. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
24. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials.
Li A; Varney ML; Singh RK
Clin Cancer Res; 2001 Oct; 7(10):3298-304. PubMed ID: 11595728
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 counteracts effects of cyclosporin A on extracellular matrix metabolism by human dermal fibroblasts.
Abe M; Yokoyama Y; Syuto T; Ishibuchi H; Ishikawa O
Cell Tissue Res; 2008 Aug; 333(2):281-8. PubMed ID: 18553108
[TBL] [Abstract][Full Text] [Related]
26. Loss of KAI1 expression in the progression of colorectal cancer.
Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia.
Strassmann G; Jacob CO; Evans R; Beall D; Fong M
J Immunol; 1992 Jun; 148(11):3674-8. PubMed ID: 1534101
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V
J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542
[TBL] [Abstract][Full Text] [Related]
30. Human myeloma cells promote the recruitment of osteoblast precursors: mediation by interleukin-6 and soluble interleukin-6 receptor.
Karadag A; Scutt AM; Croucher PI
J Bone Miner Res; 2000 Oct; 15(10):1935-43. PubMed ID: 11028445
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
Malinowska K; Neuwirt H; Cavarretta IT; Bektic J; Steiner H; Dietrich H; Moser PL; Fuchs D; Hobisch A; Culig Z
Endocr Relat Cancer; 2009 Mar; 16(1):155-69. PubMed ID: 19011039
[TBL] [Abstract][Full Text] [Related]
32. Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma.
Kai H; Kitadai Y; Kodama M; Cho S; Kuroda T; Ito M; Tanaka S; Ohmoto Y; Chayama K
Anticancer Res; 2005; 25(2A):709-13. PubMed ID: 15868900
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro.
Brew R; Erikson JS; West DC; Kinsella AR; Slavin J; Christmas SE
Cytokine; 2000 Jan; 12(1):78-85. PubMed ID: 10623446
[TBL] [Abstract][Full Text] [Related]
34. [Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3].
Yuan YX; Xu WF; Liu J; Chen MH; Meng H; Qu XJ
Ai Zheng; 2006 Jun; 25(6):663-70. PubMed ID: 16764758
[TBL] [Abstract][Full Text] [Related]
35. Leptin stimulates the migration of colon carcinoma cells by multiple signaling pathways.
Ratke J; Entschladen F; Niggemann B; Zänker KS; Lang K
Endocr Relat Cancer; 2010 Mar; 17(1):179-89. PubMed ID: 19952122
[TBL] [Abstract][Full Text] [Related]
36. The biology of interleukin-6 in the 21st century.
Rose-John S
Semin Immunol; 2014 Feb; 26(1):1. PubMed ID: 24556601
[No Abstract] [Full Text] [Related]
37. The IL-6 feed-forward loop: a driver of tumorigenesis.
Chang Q; Daly L; Bromberg J
Semin Immunol; 2014 Feb; 26(1):48-53. PubMed ID: 24613573
[TBL] [Abstract][Full Text] [Related]
38. The Janus Faces of IL-6 in GN.
Salama AD; Little MA
J Am Soc Nephrol; 2015 Jul; 26(7):1480-2. PubMed ID: 25655069
[No Abstract] [Full Text] [Related]
39. Kinetics of glycogen levels in asynchronous and synchronous cultures of a human colon carcinoma cell line, HT 29.
Rousset M; Chevalier G; Rousset JP; Robine-Leon S; Dussaulx E; Zweibaum A
Front Gastrointest Res; 1979; 4():73-9. PubMed ID: 428897
[No Abstract] [Full Text] [Related]
40. Comments on: Acute aerobic exercise-conditioned serum reduces colon cancer cell proliferation in vitro through interleukin-6-induced regulation of DNA damage.
Jiang Z; Yang Z
Int J Cancer; 2022 Nov; 151(9):1640-1641. PubMed ID: 35716145
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
